Add office photos
Engaged Employer
GlaxoSmithKline Pharmaceuticals
4.1
based on 1.8k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at GlaxoSmithKline Pharmaceuticals
Company Summary
GlaxoSmithKline Pharmaceuticals is a premier pharmaceutical manufacturer in India, addressing health issues with a diverse range of medicines and vaccines.
Overall Rating
4.1/5
based on 1.8k reviews
5% above
industry average
Highly rated for
Company culture, Salary, Work-life balance
Work Policy
Hybrid
70% employees reported
Monday to Saturday
46% employees reported
Flexible timing
78% employees reported
Within city
48% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
84 employees reported
Health insurance
82 employees reported
Professional degree assistance
42 employees reported
Child care facility
35 employees reported
View all benefits
About GlaxoSmithKline Pharmaceuticals
Founded in1830 (195 yrs old)
India Employee Count1k-5k
Global Employee Count50k-1 Lakh
HeadquartersBrentford, UnitedKingdom
Office Locations
--
Websitegsk-india.com
Primary Industry
Other Industries
View in video summary
GlaxoSmithKline Pharmaceuticals (GSK India) is the top of the pill heap. India's leading pharmaceutical manufacturer, the company makes pharmaceuticals and consumer health care products through its two manufacturing facilities in Nashik and Thane; it also has a clinical development center in Bangalore. Its products include those targeting problems with infections, gynecology, dermatology, diabetes, and the cardiovascular system. Top sellers are Augmentin, Zinetac, Calpol, Phexin, and Betnesol. GSK India also makes vaccines to treat or prevent hepatitis A and B, the flu, chickenpox, and tetanus. Its distribution network stretches throughout the country. UK-based drugmaker GlaxoSmithKline owns GSK India.
Mission: We want to be one of the world’s most innovative, best performing and trusted healthcare company.
At GSK, we have an evolving business model for a sustainable future. With the aim to increase growth, reduce risk, and improve our long-term financial performance, it is focused around five strategic priorities - grow a diversified global business, deliver more products of value, simplify the operating model, create a culture of individual empowerment, and build trust.
Vision: our strategic priorities are underpinned by our responsible business approach and we are continually listening to stakeholders to understand their expectations better.
GlaxoSmithKline Pharmaceuticals Ratings
based on 1.8k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
1k
4
447
3
176
2
74
1
117
Category Ratings
4.1
Company culture
4.0
Salary
4.0
Work-life balance
4.0
Skill development
3.8
Work satisfaction
3.7
Job security
3.4
Promotions
GlaxoSmithKline Pharmaceuticals is rated 4.1 out of 5 stars on AmbitionBox, based on 1.8k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at GlaxoSmithKline Pharmaceuticals
based on 1.7k reviews
4.1
Rated by 277 Women
Rated 4.3 for Company culture and 4.2 for Work-life balance
4.1
Rated by 1.5k Men
Rated 4.1 for Company culture and 4.1 for Salary
Work Policy at GlaxoSmithKline Pharmaceuticals
based on 177 reviews in last 6 months
Hybrid
70%
Work from office
28%
Permanent work from home
2%
GlaxoSmithKline Pharmaceuticals Reviews
Top mentions in GlaxoSmithKline Pharmaceuticals Reviews
+ 5 more
Compare GlaxoSmithKline Pharmaceuticals with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 1.8k reviews | 4.0/5 based on 5.8k reviews | 4.1/5 based on 6.9k reviews | 5.0/5 based on 1 reviews |
Highly Rated for | Company culture Skill development Work-life balance | Salary Skill development Job security | Skill development Salary Work-life balance | Skill development Work-life balance Salary |
Critically Rated for | No critically rated category | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Hybrid 70% employees reported | Work from office 82% employees reported | Work from office 73% employees reported | - |
Rating by Women Employees | 4.1 Good rated by 277 women | 4.0 Good rated by 437 women | 4.1 Good rated by 682 women | - no rating available |
Rating by Men Employees | 4.1 Good rated by 1.5k men | 4.0 Good rated by 5k men | 4.1 Good rated by 5.8k men | - no rating available |
Job security | 3.7 Good | 3.8 Good | 3.7 Good | 4.0 Good |
View more
GlaxoSmithKline Pharmaceuticals Salaries
GlaxoSmithKline Pharmaceuticals salaries have received with an average score of 4.0 out of 5 by 1.8k employees.
Medical Business Associate
(331 salaries)
Unlock
₹3.2 L/yr - ₹10.3 L/yr
Area Business Manager
(218 salaries)
Unlock
₹6 L/yr - ₹25 L/yr
Medical Representative
(183 salaries)
Unlock
₹2 L/yr - ₹10 L/yr
Business Executive
(152 salaries)
Unlock
₹4 L/yr - ₹12 L/yr
Expert Sales Executive
(85 salaries)
Unlock
₹4 L/yr - ₹10 L/yr
Sales Executive
(82 salaries)
Unlock
₹1 L/yr - ₹10 L/yr
Pharmacy Business Associate
(71 salaries)
Unlock
₹2.2 L/yr - ₹5.2 L/yr
Management Trainee
(44 salaries)
Unlock
₹7.9 L/yr - ₹25 L/yr
Regulatory Affairs Specialist
(43 salaries)
Unlock
₹4.3 L/yr - ₹11.9 L/yr
Territory Sales Executive
(36 salaries)
Unlock
₹3.5 L/yr - ₹11.6 L/yr
GlaxoSmithKline Pharmaceuticals Interview Questions
Interview questions by designation
Top GlaxoSmithKline Pharmaceuticals interview questions and answers
Get interview-ready with top interview questions
GlaxoSmithKline Pharmaceuticals Jobs
Popular Designations GlaxoSmithKline Pharmaceuticals Hires for
Popular Skills GlaxoSmithKline Pharmaceuticals Hires for
Current Openings
GlaxoSmithKline Pharmaceuticals News
View all
British pharma company GSK pauses diversity work citing Trump orders
- British pharma company GSK has paused diversity activities for UK workers.
- The company claims it is obliged to do so in response to executive orders by Donald Trump.
- GSK has also removed references to 'diversity' from its website.
- The move by GSK contrasts with its British pharma rival AstraZeneca, which has not made any changes to its diversity policies.
Guardian | 1 Mar, 2025
GSK boss Emma Walmsley could see pay rise to nearly £22m this year
- GSK's chief executive, Emma Walmsley, has the potential to receive a pay package of nearly £22m in future years.
- Walmsley's maximum pay package is contingent on the company's share price rising by at least 50% and meeting stretching targets.
- In 2021, Walmsley was paid £10.6m, down from £12.7m in 2020, primarily due to lower bonuses.
- GSK aims to align executive pay with US pharmaceutical companies and incentivize research and development progress and shareholder returns.
Guardian | 27 Feb, 2025
Britannia Share Price Target 2025 2026 to 2030
- Britannia Industries Limited, a multinational company, has a strong presence in the bakery and dairy sectors since 1892.
- The company's stock has shown an upward trend supported by positive financial results, attracting investors.
- Investors should make informed decisions and avoid common mistakes when considering Britannia shares.
- Britannia's Share Price Target for 2025 is projected to range between Rs 4,610.17 and Rs 7,462.01.
- Expert insights suggest maximum and minimum targets for each month to help investors with informed decisions.
- The Share Price Target for Britannia from 2026 to 2030 is expected to range between Rs 5,245.68 and Rs 14,313.06.
- Detailed forecasts on Britannia stock trends and future growth potential are essential for long-term investment strategies.
- Britannia's competitors in the market cap include Nestle, GlaxoSmithKline, Adani Wilmar, and Jubilant Food.
- The historic performance of Britannia's share prices showcases a consistent upward trajectory, favoring long-term investments.
- Stock market predictions are subject to change, and investors are advised to seek expert advice before making investment decisions.
VIE Stories | 21 Feb, 2025
GSK Pharma Q3 Results: Profit Increases Fivefold, Beats Estimates
- Glaxosmithkline Pharmaceuticals reported a profit of Rs 230 crore in third quarter, a 400% year-on-year jump from Rs 46 crore.
- The firm's revenue rose 18% to Rs 949 crore compared to Rs 805 crore in the previous fiscal, exceeding the estimate of Rs 876 crore.
- Its earnings before interest, taxes, depreciation and amoritisation increased by 34% to Rs 292 crore, compared to Rs 218 crore in the same period last year. This surpassed the Bloomberg estimate of Rs 250 crore.
- Shares of Glaxosmithkline Pharmaceuticals rose as much as 2.48% during the day to Rs 2,048.30 apiece on the National Stock Exchange.
Bloomberg Quint | 14 Feb, 2025
Union Budget 2025: Cancer medicines and patient assistance programmes come in for reprieve
- Medicines from multinational companies, including Pembrolizumab (MSD Pharma), Lorlatinib (Pfizer), Ribociclib (Novartis), Selumetinib (Astra Zeneca), Teclistamab (Johnson & Johnson), Cetuximab (Merck Specialities), Brentuximab Vedotin (Takeda); Mepolizumab (GSK Pharma), Risdiplam Powder (Roche), Luspatercept (Bristol Myers Squibb) are among the 37 listed to get Basic Customs Duty exemptions, provided they are given free.
- Additionally, the budget proposes to add 13 new patient assistance programs for supplying medicines free of cost to patients.
- 36 lifesaving drugs and medicines will be added to the list of medicines fully exempted from Basic Customs Duty (BCD), and 6 lifesaving medicines will be eligible for concessional customs duty of 5 percent.
- The budget also plans to establish 200 daycare cancer centers in all district hospitals in the next three years.
HinduBusinessLine | 1 Feb, 2025
GSK strikes £50m deal with Oxford University on cancer vaccines; dollar rises after Trump U-turn on Colombia tariffs – business live
- GlaxoSmithKline (GSK) signs £50m deal with Oxford University on cancer vaccines
- Dollar rises after Trump reverses decision on Colombia tariffs
- European tech stocks decline while Chinese AI company DeepSeek launches new product
- Corporate updates expected from Boeing, Starbucks, Intel, IBM, Chevron, and Exxon Mobil
Guardian | 27 Jan, 2025
When Should Investors Rotate from the Magnificent 7 To Dividend Growth?
- Investors may need to prepare for rotating out of the magnificent seven stocks (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) and consider dividend growth stocks.
- The 10-year U.S. treasury bond yields are approaching 5.0%, indicating a potential asset class rotation.
- Defensive industry stocks such as General Dynamics, Lockheed Martin, and RTX, as well as drug sector stocks like Bristol-Myers, Merck, Pfizer, GSK, and AbbVie, are worth considering.
- ETFs like Schwab's SCHD that offer dividends and growth could also be a viable option.
Baystreet | 8 Jan, 2025
GSK marks century in India with commemorative ₹5 stamp
- GlaxoSmithKline (GSK) commemorated its century in India with a ₹5 stamp.
- The stamp features the picture of GSK's Worli site in Mumbai.
- The stamp and a 'special cover' will be available at 1100 post offices across the country.
- GSK is listed in India for over six decades and participates in 19 global clinical trials.
HinduBusinessLine | 4 Jan, 2025
Why are Biogen, Pfizer, and GSK Trading at a Discount?
- Biogen (BIIB), Pfizer (PFE), and GSK (GSK) are trading at a discount.
- Biogen lacks growth catalysts and slow demand for its Alzheimer's drug.
- Pfizer's tailwinds from Paxlovid will slow down after flu season.
- GSK reported positive results for a drug treating multiple myeloma.
Baystreet | 17 Dec, 2024
Palantir and Disney are Winners, AMAT, OMC and MRNA are Not
- Palantir (PLTR) announced the transfer of its Class A stock to the Nasdaq from the NYSE, causing its stock to rise by 11.14%.
- Disney (DIS) reported revenue growth of 6.3% Y/Y and forecasts high single-digit adjusted EPS growth for FY 2025, leading to a 15% increase in its stock.
- Omnicom Group (OMC) reported a 7% increase in operating income but experienced a 7.79% decline in its stock.
- Moderna (MRNA) faced a decline of 7.34% due to concerns that RFK Jr. leading the U.S. Department of Health and Human Services could impact the vaccine market.
- Moderna's peers, GSK, Novavax (NVAX), and BioNTech (BNTX), also traded lower.
Baystreet | 18 Nov, 2024
Powered by
GlaxoSmithKline Pharmaceuticals Subsidiaries
Novartis Consumer Health
4.5
• 9 reviews
Report error
GlaxoSmithKline Pharmaceuticals Offices
Compare GlaxoSmithKline Pharmaceuticals with
Biocon Limited
3.9
Zydus Lifesciences
4.1
Aurobindo Pharma
4.0
Lupin
4.2
Torrent Pharmaceuticals
3.9
Glenmark Pharmaceuticals
3.9
DIVI'S Laboratories
3.7
Hetero
3.9
Abbott
4.1
Micro Labs
3.6
Pfizer
4.0
Biological E
4.2
Granules India
3.8
Gland Pharma
3.8
Sanofi
4.2
Unichem Laboratories
3.8
Fresenius Kabi
4.2
Piramal Pharma
3.9
ACG Worldwide
4.0
Novo Nordisk
4.1
Contribute & help others!
You can choose to be anonymous
Companies Similar to GlaxoSmithKline Pharmaceuticals
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.8k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.9k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.7k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.9k reviews
DIVI'S Laboratories
Pharma
3.7
• 1.4k reviews
GlaxoSmithKline Pharmaceuticals FAQs
When was GlaxoSmithKline Pharmaceuticals founded?
GlaxoSmithKline Pharmaceuticals was founded in 1830. The company has been operating for 195 years primarily in the Pharma sector.
Where is the GlaxoSmithKline Pharmaceuticals headquarters located?
GlaxoSmithKline Pharmaceuticals is headquartered in Brentford.
How many employees does GlaxoSmithKline Pharmaceuticals have in India?
GlaxoSmithKline Pharmaceuticals currently has more than 3,200+ employees in India. Marketing & Communication department appears to have the highest employee count in GlaxoSmithKline Pharmaceuticals based on the number of reviews submitted on AmbitionBox.
Does GlaxoSmithKline Pharmaceuticals have good work-life balance?
GlaxoSmithKline Pharmaceuticals has a work-life balance rating of 4.0 out of 5 based on 1,800+ employee reviews on AmbitionBox. 80% employees rated GlaxoSmithKline Pharmaceuticals 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read GlaxoSmithKline Pharmaceuticals work-life balance reviews for more details
Is GlaxoSmithKline Pharmaceuticals good for career growth?
Career growth at GlaxoSmithKline Pharmaceuticals is rated as moderate, with a promotions and appraisal rating of 3.4. 20% employees rated GlaxoSmithKline Pharmaceuticals 3 or below, while 80% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading GlaxoSmithKline Pharmaceuticals promotions/appraisals reviews for more detailed insights.
What are the pros of working in GlaxoSmithKline Pharmaceuticals?
Working at GlaxoSmithKline Pharmaceuticals offers several advantages that make it an appealing place for employees. The company is highly rated for company culture, salary & benefits and skill development, based on 1,800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
